OTC Eye Solution Recalled

Teva Pharmaceuticals USA Inc is recalling 715,632 bottles of Clear Eyes, Once Daily, Eye Allergy Itch Relief for failing to meet impurities specifications. According to the March 22, 2023, US Food and Drug Administration (FDA) Enforcement Report, an out-of-specification result was obtained for an unspecified impurity during stability testing.

The recall affects Clear Eyes, Once Daily, Eye Allergy Itch Relief (olopatadine hydrochloride ophthalmic solution, 0.2%), 2.5-mL bottles (UPC 678112000708, NDC 67172-504-01), from lots 114349 (Exp 5/23), 117396 (Exp. 9/23), 120128 (Exp 11/23), 114371 (Exp 6/23), and 123781 (Exp 2/24). The product was distributed by Medtech Products Inc, Tarrytown, New York, throughout the United States.

Teva Pharmaceuticals voluntarily initiated the recall February 23, 2023. On March 20, 2023, the FDA designated the recall Class II, communicating use of the product may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.

Clear Eyes, Once Daily, Eye Allergy Itch Relief is an over-the-counter antihistamine used to temporarily relieve itchy eyes.